Literature DB >> 3039952

Otorhinolaryngological findings in AIDS patients: a study of 63 cases.

R J Hadderingh, R A Tange, S A Danner, J K Eeftinck Schattenkerk.   

Abstract

Patients with acquired immunodeficiency syndrome (AIDS) frequently show signs and symptoms involving the head and neck. We reviewed the clinical histories of 63 cases with AIDS, with patients treated from 1982 to December 1985, in our hospital. Findings referable to the head and neck were seen in 43 patients. Comparison with a previous study in San Francisco revealed remarkable differences. We found otolaryngological manifestations in 68% of the patients in contrast to 41% in this latter study. We saw more rapidly increasing neck masses, a greater incidence of shortness of breath and chronic cough, and an increased occurrence of candidiasis. The number of cases with Kaposi's sarcoma lesions was equal in both studies.

Entities:  

Mesh:

Year:  1987        PMID: 3039952     DOI: 10.1007/BF00453483

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  11 in total

1.  Perspectives on the future of AIDS.

Authors:  T C Quinn
Journal:  JAMA       Date:  1985-01-11       Impact factor: 56.272

2.  Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-03-14       Impact factor: 17.586

3.  [The acquired immunodeficiency syndrome (AIDS)].

Authors:  S A Danner; R A Coutinho
Journal:  Ned Tijdschr Geneeskd       Date:  1983-05-07

4.  Pneumocystis pneumonia--Los Angeles.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-06-05       Impact factor: 17.586

5.  Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-07-03       Impact factor: 17.586

6.  Rising prevalence of human T-lymphotropic virus type III (HTLV-III) infection in homosexual men in London.

Authors:  C A Carne; I V Weller; S Sutherland; R Cheingsong-Popov; R B Ferns; P Williams; A Mindel; R Tedder; M W Adler
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

7.  Otolaryngologic and head and neck manifestations of acquired immunodeficiency syndrome (AIDS).

Authors:  D C Marcusen; C D Sooy
Journal:  Laryngoscope       Date:  1985-04       Impact factor: 3.325

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Heterosexual and homosexual patients with the acquired immunodeficiency syndrome. A comparison of surveillance, interview, and laboratory data.

Authors:  M E Guinan; P A Thomas; P F Pinsky; J T Goodrich; R M Selik; H W Jaffe; H W Haverkos; G Noble; J W Curran
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

10.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  3 in total

1.  Mastoiditis, lymphoma, and AIDS.

Authors:  T Lowry; L Raja; A Verghese
Journal:  West J Med       Date:  1998-09

Review 2.  High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patients.

Authors:  A P Riederer; G O Grein; J R Bogner
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

3.  Changing Trends of HIV/AIDS in Otorhinolaryngology with CD4 (+) Count Correlation.

Authors:  Y K Kirti; J K Yashveer; V K Poorey
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.